DANIEL CLAUDIO DE OLIVEIRA GOMES

Title: Doctor
Research groups: CNPq (Google Translator version)
Curriculum: https://lattes.cnpq.br/3965075540969796
Orcid: https://orcid.org/0000000206630981

Participation in projects:

Title	Starting date	Deadline (months)	Participation in the project
Blocking of Sestrins, PD-1 and p38 MAP kinase signalling to enhance anti-Leishmania specific immunity in humans	01/07/2018	60	Coordinator *
	22/05/2017	48	Coordinator *
	22/05/2017	48	Coordinator *
	01/10/2016	24	Coordinator *
	03/06/2013	24	Coordinator *

Pages

Participants in examination boards:

Title	Name	Defense date	Course
STUDY of the Tumor Microenvironment in Carcinoma Oral and Oropharyngeal epidermoid and Its Implication prognosis	CAMILA BATISTA DANIEL	12/02/2020	M.Sc. in Biotechnology
USE OF ADJUVANTS (CAF 09, CAF 01 AND MPL) MUCOSA-COMPATIBLE IN THE FORMULATION OF VACCINES AGAINST VICERAL LEISHMANIOSIS.	ANDRES FELIPE MENDEZ COREA	29/03/2018	M.Sc. in Biotechnology
EVALUATION OF Bacteriocin Leishmanicide Potential	DIVAN HENRIQUE FERNANDES BARCELOS	21/03/2018	M.Sc. in Biotechnology
Antimicrobial Activity and Antibiofilm of Epigallocatechin Galate in Staphylococcus Aureus	CARINA KNIDEL	06/03/2018	M.Sc. in Biotechnology
Evaluation of the Role of the Tlr1 / 2 Agonist (pam3csk4) in Potentiating the Protective Effect of Laag Vaccine Administered Via Intranasal Against Visceral Murine Leishmaniasis.	EMMANOEL LOSS DIAS	05/09/2016	M.Sc. in Biotechnology

Pages

Disciplines taught:

Academic term	Code	Name	Hours	Course
2024/2	PBIO0018	Gene and Cell Therapy	30	Master's degree in biotechnology
2024/2	PBIO0018	Gene and Cell Therapy	30	Doctorate in biotechnology
2024/1	PBIO0026	Teaching Internship	30	Doctorate in biotechnology
2021/2	PBIO0023	Special Topics in Biotechnology I	30	Master's degree in biotechnology

Guided Students:

Name	Title	Defense date	Role	Type
PAOLA DE OLIVEIRA LOPES	ANALYSIS OF P16, NKG2D AND MICA/B EXPRESSION IN PULMONARY INJURY OF PATIENTS WITH LETHAL COVID-19	12/08/2022	Advisor *	MSc dissertation
ANDRES FELIPE MENDEZ COREA	USE OF ADJUVANTS (CAF 09, CAF 01 AND MPL) MUCOSA-COMPATIBLE IN THE FORMULATION OF VACCINES AGAINST VICERAL LEISHMANIOSIS.	29/03/2018	Advisor *	MSc dissertation
DIVAN HENRIQUE FERNANDES BARCELOS	EVALUATION OF Bacteriocin Leishmanicide Potential	21/03/2018	Advisor *	MSc dissertation
EMMANOEL LOSS DIAS	Evaluation of the Role of the Tlr1 / 2 Agonist (pam3csk4) in Potentiating the Protective Effect of Laag Vaccine Administered Via Intranasal Against Visceral Murine Leishmaniasis.	05/09/2016	Advisor *	MSc dissertation
ESTEVÃO CARLOS SILVA BARCELOS	EVALUATION OF RESVERATROL THERAPEUTIC POTENTIAL LIKE A NEW DRUG AGAINST VISCERAL LEISHMANIOSIS	04/03/2016	Advisor *	MSc dissertation

Pages